HomeTagsEverest Medicines Limited

Tag: Everest Medicines Limited

spot_imgspot_img

Everest Medicines Announces the First Prescription of VELSIPITY(R) Issued in Macau

Officially Beginning to Benefit Asian Patients Everest Medicines (HKG: 1952, Everest, or the Company), a biopharmaceutical company focused on the discovery, clinical development, manufacturing...

Everest Medicines Announces Positive Results in Preliminary Analysis of Phase 1b/2a Clinical Trial of EVER001, a Novel BTK Inhibitor for the Treatment of Primary...

Patients in the low-dose cohort who have completed 36 weeks of treatment, 9 out of 11 (81.8%) achieved overall clinical remission and 10...

Everest Medicines Announces Acceptance of VELSIPITY New Drug Application in Hong Kong

Everest Medicines (HKG: 1952, Everest, or the Company), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read

spot_img